The SARS-CoV-2 spike protein is pivotal in the COVID-19 virus’s life cycle, facilitating viral attachment to host cells. It is believed that targeting this viral protein could be key to developing effective COVID-19 prophylactics. Using in silico techniques, this study sought to virtually screen for compounds from the literature that strongly bind and disrupt the stability of the HSPA8–spike protein complex. To evaluate the interactions between the individual proteins and the protein complex attained from protein–protein docking using BioLuminate, molecular docking was performed using the Maestro Schrodinger Suite. The screened small molecules met all bioavailability conditions, Lipinski’s and Veber’s rules, and the required medicinal chemistry properties. Protein–protein docking of the spike protein and HSPA8 identified the optimal pose with a PIPER cluster size of 65, a PIPER pose energy of −748.301 kcal/mol, and a PIPER pose score of −101.189 kcal/mol. Two small molecules, NSC36398 and NSC281245, showed promising docking scores against the spike protein individually and in a complex with HSPA8. NSC36398 had a docking score of −7.934 kcal/mol and a binding free energy of −39.52 kcal/mol with the viral spike protein and a docking score of −8.029 kcal/mol and binding free energy of −38.61 with the viral protein in complex with HSPA8, respectively. Mevastatin had a docking score of −5.099 kcal/mol and a binding free energy of −44.49 kcal/mol with the viral protein and a docking score of −5.285 kcal/mol and binding free energy of −36.65 kcal/mol with the viral protein in complex with HSPA8, respectively. These results, supported by extensive 2D interaction diagrams, suggest that NSC36398 and NSC281245 are potential drug candidates targeting SARS-CoV-2 spike protein.
Coronavirus disease 2019 (COVID-19) is a novel disease that had devastating effects on human lives and the country’s economies worldwide. This disease shows similar parasitic traits, requiring the host’s biomolecules for its survival and propagation. Spike glycoproteins severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 spike protein) located on the surface of the COVID-19 virus serve as a potential hotspot for antiviral drug development based on their structure. COVID-19 virus calls into action the chaperonin system that assists the attacker, hence favoring infection. To investigate the interaction that occurs between SARS-CoV-2 spike protein and human molecular chaperons (HSPA8 and sHSP27), a series of steps were carried out which included sequence attainment and analysis, followed by multiple sequence alignment, homology modeling, and protein–protein docking which we performed using Cluspro to predict the interactions between SARS-CoV-2 spike protein and human molecular chaperones of interest. Our findings depicted that SARS-CoV-2 spike protein consists of three distinct chains, chains A, B, and C, which interact forming hydrogen bonds, hydrophobic interactions, and electrostatic interactions with both human HSPA8 and HSP27 with −828.3 and −827.9 kcal/mol as binding energies for human HSPA8 and −1166.7 and −1165.9 kcal/mol for HSP27.
10 July 2024 in INNOSC Theranostics and Pharmacological Sciences
Diabetes is a severe chronic illness that has impacted thousands of individuals worldwide. It is caused by the body’s failure to produce insulin or insufficient production of insulin. While diabetes is not curable, it can be managed with injectable insulin, which decreases blood glucose levels. However, this treatment has several disadvantages that can affect a patient’s health, and it is often unaffordable for some individuals. Previous studies have suggested that phytochemicals can improve insulin sensitivity. Due to the presence of therapeutic phytochemicals in natural plants, medicinal plants emerge as potential candidates for treating diabetes. In addition, compared to conventional diabetes treatments, phytochemical treatment may be affordable for all diabetics and has fewer side effects. This review primarily focuses on the symptoms and treatment options for the four known types of diabetes: type 1 diabetes mellitus, type 2 diabetes mellitus, type 3c diabetes mellitus, and neonatal diabetes. The article reviews medicinal plants that have been used to treat diabetes effectively with minimum side effects, such as Momordica charantia L., Syzygium cumini (L.) Skeels, and Ocimum tenuiflorum L., among others. In addition, some newly approved drugs, such as tirzepatide, sergliflozin, saxagliptin, and liraglutide, recommended for treating patients suffering from various forms of diabetes, are discussed.
We present a computational study that precedes the potential interactions between SARS-CoV-2 helicase (NSP13) and selected host proteins implicated in chaperone-assisted folding and polyamine metabolism. Using structure-based modelling and protein–protein docking (BioLuminate v4.6), followed by all-atom molecular dynamics (MD) simulations (GROMACS v2018.6), and comparative MM-GBSA scoring (HawkDock v2), we evaluated the stability and interface properties of NSP13 complexes with cytosolic heat shock proteins; heat shock protein 40 (HSP40), heat shock protein 70 (HSP70), heat shock protein 90 (HSP90) and the polyamine biosynthesis enzyme ornithine decarboxylase (ODC). Docking, MD, and interface analyses indicate distinct complex behaviours: HSP70-NSP13 complexes sampled compact conformations, HSP90-NSP13 ensembles displayed greater conformational heterogeneity but more favourable comparative MM-GBSA estimates, and ODC-NSP13 interfaces were comparatively well packed. Per-residue contact mapping identified a small set of recurrent NSP13 residues, Lys22 and Asn51, as putative interaction hotspots. The reported findings herein generate testable hypotheses about NSP13 recruitment of host chaperones and modulation of polyamine metabolism that may inform downstream experimental studies.
Coronavirus disease 2019 continues to pose global health challenges, with the pandemic significantly burdening several economies, healthcare systems, and the social lives of individuals. Furthermore, new cases continue to be reported, underscoring the need for therapeutic strategies targeting conserved regions and host–virus interactions. Building on earlier virtual screening for small molecules, all-atom molecular dynamics simulations and binding-free-energy calculations were performed to elucidate how the two previously identified small molecules (NSC36398 and NSC281245) may affect the dynamic behaviour of the interaction between heat shock 70 kDa protein 8 (HSPA8) and the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike glycoprotein. Post-MD analyses refined prior docking predictions, where NSC281245 was found to bind tightly to the complex with limited perturbations at the HSPA8-spike protein interaction surface, whereas NSC36398 appeared to induce allosteric-like domain-level destabilisation effects while maintaining stable polar contacts with the protein. Our findings demonstrate the potential of NSC36398 as a promising modulator for disrupting the HSPA8-spike protein complex, which may serve as a structural lead for designing next-generation inhibitors of host–virus interactions.
COVID-19 pandemic significantly disrupted global economies, health systems, and people’s social lives. To this day, some countries still report new cases of COVID-19 infections supporting the need for therapeutic strategies to combat this disease, tar-geting conserved regions within the viral proteins and key host proteins involved in viral entry and replication. This study is built on a previous publication that virtually screened for small molecules strongly binding to the HSPA8–spike protein complex through molecular docking simulations. The current study aimed to provide in-depth insights into the ligand-mediated disruptions of the HSPA8–spike protein complex, focusing on NSC36398 and NSC281245 small molecules. An all-atom molecular dy-namics simulation was performed using GROMACS v2018.6 to determine the dynamic behaviour of the HSPA8–spike protein complex in ligand-free and ligand-bound sys-tems. Post-MD analysis was performed using various tools and software, focusing mainly on structural analysis, conformational dynamics analysis, interaction analysis, and binding free energy calculations. The post-MD analysis validated the previous docking results, highlighting NSC36398 and NSC281245 as promising HSPA8–spike protein complex inhibitors. NSC36398 displayed a modest and stable binding interac-tion characterised by multiple hydrogen bonds and allosterically destabilising the HSPA8–spike protein interaction surface. NSC281245 displayed strong binding to the protein complex with minimal allosteric disruption. These findings suggest that NSC36398 is a promising allosteric inhibitor for HSPA8–spike protein complex, and NSC281245 is also a promising candidate, providing a framework for designing next-generation small-molecule compounds with inhibitory properties towards the host-viral interaction.